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Abstract.  Treatment of diabetes mellitus is intended to reduce the risk of blindness, kidney failure, 
neuropathy and heart disease that can develop due to the chronic increase in the blood glucose level. The 
selected hypoglycemic agents should be effective, safe and readily available. The widely used agents work by 
interrupting enzymes responsible for glucose regulation. Those enzymes are α-amilase, α-glucosidase, 
dipeptidyl peptidase-IV, aldose reductase and angiotensin converting enzyme. A medicinal plant, fenugreek 
(Trigonella foenum-graecum) has been used as an antidiabetic folk medicine. This review provides 
information related to in vitro studies showing antihyperglycemic activity of fenugreek along with an in vivo 
study in animals. In addition, potential phytochemicals that have been isolated from this plant are described 
and play a role in the searching for the most potent agents for diabetes mellitus therapy. 
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I INTRODUCTION 
 
Diabetes is a chronic disease characterized by 
an increase in glucose level as the result of 
insufficient insulin production, and/or 
decreased glucose uptake by cells, and is 
sometimes associated with free radical 
formation [1]. Diabetes therapy includes insulin 
for type I diabetes and antidiabetic oral (ADO) 
drugs for type II diabetes. Due to adverse 
effects of ADOs and economic reasons in some 
areas, herbal medicines has been widely used as 
an alternative therapy even in children [2]. 
Since the use of these natural sources is 
common, their safety and effectiveness should 
be ascertained. Herbal medicine is known to be 
effective in improving diabetes by several 
mechanisms one of which is by inhibiting 
enzymes regulating glucose metabolism. These 
include α-amylase, α-glucosidase, dipeptidyl 
peptidase-IV (DPP-IV), aldose reductase and 
angiotensin converting enzyme (ACE). The 
suppression of these enzymes by secondary 
metabolites found in medicinal plants cause the 
release of insulin, and increase glucose uptake 
thereby lowering the glucose level in the blood. 
Flavonoids inhibit α-amylase, α-glucosidase, 
aldose reductase and ACE. Triterpenoids and 
phenolic compounds disrupt DPP-IV [3]. 
Among medicinal plants, fenugreek is one that 
has been extensively studied due to its 
promising activity against diabetes. In daily 
use, fenugreek is usually mixed with other 
spices used as cooking ingredients, boiled and 
prepared like tea or as syrup, or combined with 
vanilla in cakes. Different parts of fenugreek 
have been used as folk medicine and have been 
noted to show potent anticancer, antioxidant, 
antidiabetic, antihyperlipidemic, and anti-
inflammatory activity [4]. Some researchers 
have examined its action against enzymes and 
have isolated compounds from it that contribute 
to its in hypoglycemic activity which will be 
described below.  
 
Trigonella foenum : a review of hypoglycemic activity 
(Suryawati, Safrida, Firdausa Sarah, Azizah Vonna and Vera Dewi Mulia) 
 
73 
In vitro study on activity against glucose 
regulating enzymes 
 
against α-amylase  
α-amylase plays  a role in the breakdown of 
starch at the first step by stimulating the lysis of 
the 1,4-glucosidase bond. The inhibition of this 
enzyme decreases the absorption of glucose 
into the bloodstream, which is reflected in a 
lower postprandial glucose value. Activity  
Table 1 Activity of fenugreek against enzymes 
 
Trigonella 
extract 
Affected 
enzymes 
References 
Ethyl acetate 
extract of 
leaves 
α-amylase, α- 
glucosidase 
[5] 
Methanolic 
extract of seeds 
α-amylase, α- 
glucosidase 
[6] 
Ethanolic 
extract of seeds 
DPP-IV [7] 
Aqueous 
extract of seeds 
Aldose 
reductase 
[8] 
Essential oil of 
fenugreek 
seeds 
Angiotensin 
converting 
enzyme (ACE) 
[9] 
 
A study on extracts of fenugreek leaves showed 
that the ethyl acetate extract demonstrated a 
better inhibitory activity (250 µg/ml giving 
64.55% inhibition) against α-amylase compared 
to the water extract [5]. Using 4 different 
solvents (methanol, chloroform, 
dichloromethane, hexane), another study 
determined the IC50 of a seed extract, which 
showed moderate to weak inhibition activity 
(IC50 less than 127 µg/ml) with the methanol 
extract showing the best activity [6]. A 
combination of  omega 3 and fenugreek terpene 
disrupted amylase and maltase, thereby leading 
to a decline in blood glucose level [9]. 
Activity against α- glucosidase 
α-amylase and α- glucosidase are involved in 
breaking carbohydrates down to release 
glucose. Similar to its activity against α-
amylase, the leaves of fenugreek extracted 
using ethyl acetate showing more potent 
activity against glucosidase compared with the 
water extract glucosidase [5]. The seed extract 
displayed medium to minor activity against the 
enzyme (IC50 less than 61 µg/ml) using 
different polar solvents (methanol, chloroform, 
dichloromethane, hexane) with methanol 
showing the best activity [6]. 
Activity against DPP-IV 
DPP-IV contributes to the severity of diabetes. 
DPP-IV degrades GLP-1, another enzyme that 
stimulates insulin production and suppresses the 
release of glucagon [10]. Inhibition of DPP-IV 
results in a decrease in glucose levels in the 
blood. Sitagliptin is one of the conventional 
drugs that works by disrupting  DPP-IV and 
corrects HbA1c level after 2-3 months of use 
[11]. Since its approval for clinical use, its 
adverse effects had not been documented 
sufficiently. Therefore, research into a better 
DPP-IV antagonist is ongoing. Some 
Indonesian medicinal plants demonstrated 
excellent activities against DPP-IV, and one of 
them is fenugreek. An ethanol extract of 
fenugreek seeds showed a potent inhibitory 
activity (71.29±0.33%) against DPP-IV which 
was almost similar to the standard drug, 
sitagliptin (74.77±0.3%) [7]. This finding could 
be a start to produce a new DPP-IV antagonist 
with fewer adverse effects. 
Activity against aldose reductase 
In a two-step process named the polyol 
pathway, aldose reductase converts glucose to 
sorbitol with the help of cofactor NADPH 
followed by the metabolism of sorbitol to 
fructose. This process contributes to the 
development of diabetes complications in 
which hyperglycemia causes more glucose to 
enter the polyol pathway. In one study, an 
aqueous extract of fenugreek seed inhibited the 
rat lens aldose reductase enzyme with IC50 
0.24± 0.03 mg/mL [8]. Phytochemicals of 
fenugreek demonstrated a great affinity to 
aldose reductase which meant that they bound 
tightly to the enzyme and thereby could 
maximize their inhibitory activity [12]. 
Activity against ACE 
ACE activity is associated with diabetes 
severity. ACE inhibitors such as captopril 
prevent diabetic complications such as heart 
disease and retinopathy (Ramos-nino & Blumen 
2009). In diabetic rats, the activity of plasma 
ACE increased 45% compared to normal rats. 
Terpene from fenugreek combined with omega 
3 decreased ACE activity as much 38% [13]. 
Isolated Antidiabetic Compounds 
An ethanol extract of fenugreek showed 
excellent antioxidant activity. Using several 
different methods, one study revealed the 
presence of phenolic components, tannins and 
flavonoids [14]. There have been researchers 
that succeeded in isolating compounds 
contributing to hypoglycemic actions. They 
were trigonelline, 4-hydroxyisoleucine (4-HIL), 
diosgenin, quercetin, and galactomannan, 
depicted in Table 2. Trigonelline is one of the 
alkaloids detected in fenugreek seeds. The 
compound showed a hypoglycemic effect that 
was higher compared to a crude extract of 
fenugreek [15]. 
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Table 2. Isolated compounds from fenugreek 
Isolated 
compounds 
(Ref.) 
Structure 
Trigonelline 
[16] 
 
4-
hydroxyisoleuci
ne (4-HIL) 
[16] 
 
 
 
 
Diosgenin 
[17] 
 
 
 
Quercetin 
[16] 
 
Galactomannan 
[18] 
 
 
This highlights the importance of purification to 
obtain trigonelline in order to produce better 
antidiabetic activity. A study that employed 
experimental rats fed high fat diet and low dose 
streptozosin succeeded in producing a diabetic 
rat model that was used to examine the pure 
trigonelline’s antihyperglycemia effect. 
Trigonelline 150 mg/kg was given orally to 
diabetic rats. All observed parameters were 
compared to normal rats, an untreated diabetic 
group and a metformin-treated group. The 
parameters were oral glucose tolerance profile, 
fasting blood glucose level, glycosylated 
hemoglobin (HbA1c), insulin resistance, 
glucose content, and lipid parameters. The 
results showed that the administration of 
trigonelline restored the ability of the body to 
manage glucose levels. The trigonelline-treated 
rats showed almost similar glucose tolerance 
profiles to normal and metformin-treated rats in 
which glucose level significantly decreased 
after 60 minutes. This was different from the 
untreated diabetic group where the decline in 
glucose level was very slow, from 60 to 120 
minutes. Trigonelline also improved the fasting 
blood glucose level (136.86 ± 5.31(mg/dl), 
insulin resistance (12.08 ± 0.35 µU/ml) and 
HbA1c (7.14 ± 0.35%). The study also showed 
an improvement in glucose content along with 
the repair of hepatic cells as reflected by a 
decrease in ALT [19]. 
4-hydroxyisoleucine (4-HIL), is an amino acid 
isolated from fenugreek seeds. It was observed 
to benefit insulin-resistant diabetic and obese 
patients [20]. The intravenous injection of 4-
HIL (18 mg/kg) into normal rats stimulated the 
release of insulin and reduced glucose in a 
greater amount (2-3 fold) compared to control 
rats (without 4-HIL). Daily administration of 4-
HIL (50 mg/kg) for 6 days resulted in a better 
glucose tolerance profile (higher release and a 
lower blood glucose level) compared to diabetic 
rats [21]. It also improved the activity of 4-HIL 
which was slightly better (fasting blood 
glucose: 173.6 ± 7.4 mg/dl) than fenofibrate 
(180.0 ± 8.3 mg/dl). 4-HIL increased 
expression of genes (AMPK, AKT, 
PPARGC1A and PPARGC1B) responsible for 
mitochondrial biogenesis and increased 
expression of glucose transporter, which in turn 
increased glucose use[22]. 
Fenugreek saponin was identified to have 
hypoglycemic activity shown as an increase in 
free hemoglobin. It was later found that one of 
the therapeutic saponins was diosgenin. The 
oral administration of 10 mg/kg diosgenin 
improved glucose level, HbA1c level and 
antioxidant enzymes after 30 days of use. No 
toxic effect was observed after the use of 500 
mg/kg [17].  
The polyphenolic fraction of fenugreek 
displayed antihyperglycemic actions when 
given 200 mg/kg to fructose-fed rats. Its 
antidiabetic activity was comparable to standard 
quercetin and metformin. Quercetin was 
isolated from fenugreek stems [4]. It was 
observed to reduce STZ-induced rat blood 
glucose and glycated hemoglobin at a dose of 
100 mg/kg [23]. 
Galactomannan is a soluble fiber detected in 
fenugreek seeds. It is part of a class of 
polysaccharides that prevent the absorption of 
glucose by disrupting glucose regulating 
enzymes [13]. Consumption of  galactomannan 
(2.5 - 5% of the diet)  by sucrose-fed rats 
reduced their body weight, meal amount intake 
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and insulin level in the blood [24]. A study 
evaluating the effect of using 50, 100, and 200 
mg/kg galactomannan in alloxan-induced rats 
revealed that the hypoglycemic activity 
increased with an increased dose [18].  
CONCLUSION 
Fenugreek exerts a promising hypoglycemic 
action by inhibiting the glucose regulating 
enzymes, α-amylase, α-glucosidase, dipeptidyl 
peptidase-IV, aldose reductase and ACE. 
Compounds isolated from fenugreek also 
demonstrated effects on lowering blood glucose 
levels. Future research should investigate its 
effectiveness and safety in humans or 
identification of other therapeutic compounds 
for diabetes treatment.  
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